RankingsPricing
  1. JP-listed companies
  2. SAPPORO CLINICAL LABORATORY INC.
  3. Financials
  4. Cash from operations

SAPPORO CLINICAL LABORATORY INC.JP:9776

Market cap
¥8.3B
P/E ratio
12.2x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025731-32.17%
Mar 31, 20241,078-24.66%
Mar 31, 20231,430-9.10%
Mar 31, 20221,574+87.88%
Mar 31, 2021838-33.29%
Mar 31, 20201,256+94.16%
Mar 31, 2019647-50.64%
Mar 31, 20181,310+95.68%
Mar 31, 2017670-28.89%
Mar 31, 2016942+54.42%
Mar 31, 2015610

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)